News

Praj Industries has appointed Sachin Raole (DIN: 00431438) as a Joint Managing Director & Chief Financial Officer for a period of five (5) years with effect from 30 April 2026 till 29 April 2031.

Praj Industries announced that the Board of Directors of the Company at its meeting held on 28 May 2026, inter alia, have recommended the final dividend of Rs 3.6 per equity Share (i.e. 180%) , subject to the approval of the shareholders.

Net profit of Praj Industries declined 70.84% to Rs 11.61 crore in the quarter ended March 2026 as against Rs 39.81 crore during the previous quarter ended March 2025. Sales declined 1.76% to Rs 844.56 crore in the quarter ended March 2026 as against Rs 859.68 crore during the previous quarter ended March 2025.For the full year,net profit declined 89.11% to Rs 23.84 crore in the year ended March 2026 as against Rs 218.91 crore during the previous year ended March 2025. Sales declined 1.86% to Rs 3167.88 crore in the year ended March 2026 as against Rs 3228.04 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales844.56859.68 -2 3167.883228.04 -2 OPM %2.768.76 -4.799.74 - PBDT42.5680.69 -47 181.86356.83 -49 PBT15.4758.25 -73 76.30270.39 -72 NP11.6139.81 -71 23.84218.91 -89 Powered by Capital Market - Live News

Praj Industries will hold a meeting of the Board of Directors of the Company on 28 May 2026.

Praj Industries today announced the establishment of an Advanced Precision Fermentation Lab at Praj Matrix to drive next-genera on biotechnology and accelerate India`s transition to high-performance, low-carbon biomanufacturing. Announced on the occasion of the 18th Praj Matrix Foundation Day, the initiative reflects Praj`s commitment to advancing India`s bioeconomy through cutting-edge innovation, skill development, and strong academia-industry collaboration. The new lab, one of a kind globally, will focus on high-capacity, AI-enabled precision fermentation and next-genera on bioprocesses to improve efficiency, reduce scale-up risks, and enhance process reliability. It will enable Praj and Praj HiPurity Systems (Praj`s wholly owned subsidiary in Mumbai), known for its expertise in precision fermenters and ultra-pure water systems for the pharmaceutical and biotech industries, to deliver advanced fermentation solutions to the pharmaceutical, food, cosmetics and to biofuels and beverage sectors. The facility is being developed to further strengthen Praj`s capabilities in next generation biomanufacturing. Combined with BRIC-NCCS`s strengths in microbial research, genomics, and cell culture repositories, this creates a strong synergy�integra ng discovery, process development, and high-purity manufacturing to accelerate innovation. Aligned with the Government of India`s BioE3 (Biotechnology for Economy, Environment and Employment) Initiative, steered by the Department of Biotechnology, the initiative supports the national vision of building a globally competitive, sustainable biomanufacturing ecosystem.